TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2011

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).

Hiroyuki Narahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.